Ophthalmology therapeutics market size to increase by USD 15.72 billion: North America will account for 44% of market growth - Technavio

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The ophthalmology therapeutics market by product, type, and geography - forecast and analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 6.25% and register an incremental growth of USD 15.72 billion during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF sample report

Company profiles

The ophthalmology therapeutics market report includes information on the key products and recent developments of leading vendors, including:

• AbbVie Inc.: The company offers ophthalmology therapeutics such as Vuity.
• Aldeyra Therapeutics Inc.: The company offers ophthalmology therapeutics such as Reproxalap for Dry eye treatment.
• Bausch Health Co Inc.: The company offers ophthalmology therapeutics such as Biotrue Hydration Boost Lubricant Eye Drops.
• Bayer AG: The company offers ophthalmology therapeutics such as Eyelea.
• F. Hoffmann La Roche Ltd.: The company offers ophthalmology therapeutics such as Susvimo.
• Grevis Pharmaceuticals Pvt. Ltd.
• Novartis AG
• Ocular Therapeutix Inc.
• Otsuka Pharmaceutical Co. Ltd.
• To gain access to more vendor profiles available with Technavio, buy the report!

Regional analysis

Based on region, the global ophthalmology therapeutics market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America is estimated to account for 44% of the growth of the global market over the forecast period. The growth of the market is primarily driven by the high prevalence of eye diseases such as age-related macular degeneration, glaucoma, dry eye, and various eye infections. Some of the common risk factors for eye diseases include prolonged use of corticosteroids, diabetes, a family history of eye diseases, previous eye injuries or eye surgeries, and extended exposure to sunlight.

Market dynamics

The market is driven by factors such as the increase in the prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and high uptake of anti-VEGF inhibitors. However, the high cost of treatment is hindering the market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Request a sample

Market Segmentation

• Based on product, the market is segmented into retinal disorder therapeutics, glaucoma therapeutics, dry eye disease therapeutics, eye infections and inflammation therapeutics, and other therapeutics. The retinal disorder therapeutics segment accounted for the largest share of the market in 2022.
• Based on geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America held the largest share of the market in 2022.
• Based on type, the market is segmented into prescription drugs and OTC drugs.

Related reports:

The ophthalmology devices market size is expected to increase by USD 17.09 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.1%. The increasing prevalence of ophthalmic diseases and technological advances in ophthalmology devices are notably driving the ophthalmology market growth, although factors such as high cost and limited reimbursement may impede the market growth.

The ophthalmology surgical devices market size is expected to increase by USD 3.13 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.75%. The increasing prevalence of ophthalmic diseases is notably driving the eye care surgical devices market growth, although factors such as high cost and limited reimbursements may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the ophthalmology therapeutics market between 2023 and 2027
• Precise estimation of the ophthalmology therapeutics market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about vendors

• Comprehensive analysis of factors that will challenge the growth of ophthalmology therapeutics market vendors

Browse for Technavio's health care market reports

Table of contents:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global ophthalmology therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)

• 4.3 Type Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Retinal disorder therapeutics - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)

• 6.4 Glaucoma therapeutics - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)

• 6.5 Dry eye disease therapeutics - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)

• 6.6 Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)

• 6.7 Other therapeutics - Market size and forecast 2022-2027
• Exhibit 50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Product 
• Exhibit 54: Market opportunity by Product ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments 
• Exhibit 55: Chart on Type - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Type - Market share 2022-2027 (%)

• 7.2 Comparison by Type 
• Exhibit 57: Chart on Comparison by Type
• Exhibit 58: Data Table on Comparison by Type

• 7.3 Prescription drugs - Market size and forecast 2022-2027
• Exhibit 59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)

• 7.4 OTC drugs - Market size and forecast 2022-2027
• Exhibit 63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Type 
• Exhibit 67: Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 France - Market size and forecast 2022-2027
• Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 AbbVie Inc. 
• Exhibit 116: AbbVie Inc. - Overview
• Exhibit 117: AbbVie Inc. - Product / Service
• Exhibit 118: AbbVie Inc. - Key news
• Exhibit 119: AbbVie Inc. - Key offerings

• 12.4 Aldeyra Therapeutics Inc. 
• Exhibit 120: Aldeyra Therapeutics Inc. - Overview
• Exhibit 121: Aldeyra Therapeutics Inc. - Product / Service
• Exhibit 122: Aldeyra Therapeutics Inc. - Key offerings

• 12.5 Bausch Health Co Inc. 
• Exhibit 123: Bausch Health Co Inc. - Overview
• Exhibit 124: Bausch Health Co Inc. - Business segments
• Exhibit 125: Bausch Health Co Inc. - Key news
• Exhibit 126: Bausch Health Co Inc. - Key offerings
• Exhibit 127: Bausch Health Co Inc. - Segment focus

• 12.6 Bayer AG 
• Exhibit 128: Bayer AG - Overview
• Exhibit 129: Bayer AG - Business segments
• Exhibit 130: Bayer AG - Key news
• Exhibit 131: Bayer AG - Key offerings
• Exhibit 132: Bayer AG - Segment focus

• 12.7 F. Hoffmann La Roche Ltd. 
• Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus

• 12.8 Novartis AG 
• Exhibit 138: Novartis AG - Overview
• Exhibit 139: Novartis AG - Business segments
• Exhibit 140: Novartis AG - Key offerings
• Exhibit 141: Novartis AG - Segment focus

• 12.9 Ocular Therapeutix Inc. 
• Exhibit 142: Ocular Therapeutix Inc. - Overview
• Exhibit 143: Ocular Therapeutix Inc. - Product / Service
• Exhibit 144: Ocular Therapeutix Inc. - Key offerings

• 12.10 Otsuka Pharmaceutical Co. Ltd. 
• Exhibit 145: Otsuka Pharmaceutical Co. Ltd. - Overview
• Exhibit 146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 147: Otsuka Pharmaceutical Co. Ltd. - Key offerings

• 12.11 Oxurion NV 
• Exhibit 148: Oxurion NV - Overview
• Exhibit 149: Oxurion NV - Product / Service
• Exhibit 150: Oxurion NV - Key offerings

• 12.12 Pfizer Inc. 
• Exhibit 151: Pfizer Inc. - Overview
• Exhibit 152: Pfizer Inc. - Product / Service
• Exhibit 153: Pfizer Inc. - Key news
• Exhibit 154: Pfizer Inc. - Key offerings

• 12.13 Regeneron Pharmaceuticals Inc. 
• Exhibit 155: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 156: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 157: Regeneron Pharmaceuticals Inc. - Key offerings

• 12.14 Santen Pharmaceutical Co. Ltd. 
• Exhibit 158: Santen Pharmaceutical Co. Ltd. - Overview
• Exhibit 159: Santen Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 160: Santen Pharmaceutical Co. Ltd. - Key offerings

• 12.15 Sun Pharmaceutical Industries Ltd. 
• Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.16 Teva Pharmaceutical Industries Ltd. 
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus

• 12.17 Visufarma 
• Exhibit 169: Visufarma - Overview
• Exhibit 170: Visufarma - Product / Service
• Exhibit 171: Visufarma - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 172: Inclusions checklist
• Exhibit 173: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 174: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 175: Research methodology
• Exhibit 176: Validation techniques employed for market sizing
• Exhibit 177: Information sources

• 13.5 List of abbreviations 
• Exhibit 178: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio